FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4245059944> ?p ?o ?g. }

• W4245059944 endingPage "1017" @default.
• W4245059944 startingPage "1008" @default.
• W4245059944 abstract "Insulin resistance (IR) commonly is associated with nonalcoholic steatohepatitis (NASH). To establish whether IR causes NASH, this study was undertaken to determine if improving IR would improve the histologic features that define NASH. Thirty adults with prior biopsy evidence of NASH were enrolled to receive rosiglitazone, 4 mg twice daily for 48 weeks. All patients were overweight (body mass index [BMI] > 25 kg/m2) and 23% were severely obese (BMI > 35 kg/m2); 50% had impaired glucose tolerance or diabetes. Liver biopsy specimens were obtained before beginning treatment and at treatment completion. Twenty-six patients had posttreatment biopsies; of these, 22 had initial protocol liver biopsies that met published criteria for NASH on subsequent blinded evaluation. Within this initial NASH group, the mean global necroinflammatory score significantly improved with treatment and biopsies of 10 patients (45%) no longer met published criteria for NASH after treatment. Significant improvement in hepatocellular ballooning and zone 3 perisinusoidal fibrosis also occurred. Five patients withdrew early; the 25 patients completing 48 weeks of treatment had significantly improved insulin sensitivity and mean serum alanine aminotransferase (ALT) levels (104 initially, 42 U/L at the end of treatment). Adverse effects led to withdrawal of 3 patients (10%). Weight gain occurred in 67% of patients and the median weight increase was 7.3%. Within 6 months of completing treatment, liver enzyme levels had increased to near pretreatment levels. In conclusion, improving insulin sensitivity with rosiglitazone resulted in improved histologic markers of NASH, an observation suggesting that insulin resistance contributes to its development and that improving insulin sensitivity may be important in treating this liver disease." @default.
• W4245059944 created "2022-05-12" @default.
• W4245059944 creator A5023245611 @default.
• W4245059944 creator A5053610616 @default.
• W4245059944 creator A5072014736 @default.
• W4245059944 creator A5073573770 @default.
• W4245059944 creator A5076023192 @default.
• W4245059944 date "2003-10-01" @default.
• W4245059944 modified "2023-10-15" @default.
• W4245059944 title "Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone" @default.
• W4245059944 cites W1608005125 @default.
• W4245059944 cites W1633340712 @default.
• W4245059944 cites W1639924204 @default.
• W4245059944 cites W1964000264 @default.
• W4245059944 cites W1973978057 @default.
• W4245059944 cites W1983417944 @default.
• W4245059944 cites W2006591225 @default.
• W4245059944 cites W2013326347 @default.
• W4245059944 cites W2025657436 @default.
• W4245059944 cites W2031054297 @default.
• W4245059944 cites W2037516140 @default.
• W4245059944 cites W2056726092 @default.
• W4245059944 cites W2083999496 @default.
• W4245059944 cites W2084672746 @default.
• W4245059944 cites W2085608095 @default.
• W4245059944 cites W2087829753 @default.
• W4245059944 cites W2126327417 @default.
• W4245059944 cites W2131669718 @default.
• W4245059944 cites W2137936645 @default.
• W4245059944 cites W2158822657 @default.
• W4245059944 cites W2162726387 @default.
• W4245059944 cites W2164118055 @default.
• W4245059944 cites W2169210307 @default.
• W4245059944 doi "https://doi.org/10.1002/hep.1840380427" @default.
• W4245059944 hasPublicationYear "2003" @default.
• W4245059944 type Work @default.
• W4245059944 citedByCount "310" @default.
• W4245059944 countsByYear W42450599442012 @default.
• W4245059944 countsByYear W42450599442013 @default.
• W4245059944 countsByYear W42450599442014 @default.
• W4245059944 countsByYear W42450599442015 @default.
• W4245059944 countsByYear W42450599442016 @default.
• W4245059944 countsByYear W42450599442017 @default.
• W4245059944 countsByYear W42450599442018 @default.
• W4245059944 countsByYear W42450599442019 @default.
• W4245059944 countsByYear W42450599442020 @default.
• W4245059944 countsByYear W42450599442021 @default.
• W4245059944 countsByYear W42450599442022 @default.
• W4245059944 countsByYear W42450599442023 @default.
• W4245059944 crossrefType "journal-article" @default.
• W4245059944 hasAuthorship W4245059944A5023245611 @default.
• W4245059944 hasAuthorship W4245059944A5053610616 @default.
• W4245059944 hasAuthorship W4245059944A5072014736 @default.
• W4245059944 hasAuthorship W4245059944A5073573770 @default.
• W4245059944 hasAuthorship W4245059944A5076023192 @default.
• W4245059944 hasConcept C126322002 @default.
• W4245059944 hasConcept C134018914 @default.
• W4245059944 hasConcept C2775934546 @default.
• W4245059944 hasConcept C2776175330 @default.
• W4245059944 hasConcept C2776954865 @default.
• W4245059944 hasConcept C2777180221 @default.
• W4245059944 hasConcept C2777391703 @default.
• W4245059944 hasConcept C2777766500 @default.
• W4245059944 hasConcept C2778772119 @default.
• W4245059944 hasConcept C2779134260 @default.
• W4245059944 hasConcept C2779306644 @default.
• W4245059944 hasConcept C2779478299 @default.
• W4245059944 hasConcept C2780152017 @default.
• W4245059944 hasConcept C2780221984 @default.
• W4245059944 hasConcept C2780559512 @default.
• W4245059944 hasConcept C2780586474 @default.
• W4245059944 hasConcept C3018708256 @default.
• W4245059944 hasConcept C555293320 @default.
• W4245059944 hasConcept C71924100 @default.
• W4245059944 hasConcept C90924648 @default.
• W4245059944 hasConceptScore W4245059944C126322002 @default.
• W4245059944 hasConceptScore W4245059944C134018914 @default.
• W4245059944 hasConceptScore W4245059944C2775934546 @default.
• W4245059944 hasConceptScore W4245059944C2776175330 @default.
• W4245059944 hasConceptScore W4245059944C2776954865 @default.
• W4245059944 hasConceptScore W4245059944C2777180221 @default.
• W4245059944 hasConceptScore W4245059944C2777391703 @default.
• W4245059944 hasConceptScore W4245059944C2777766500 @default.
• W4245059944 hasConceptScore W4245059944C2778772119 @default.
• W4245059944 hasConceptScore W4245059944C2779134260 @default.
• W4245059944 hasConceptScore W4245059944C2779306644 @default.
• W4245059944 hasConceptScore W4245059944C2779478299 @default.
• W4245059944 hasConceptScore W4245059944C2780152017 @default.
• W4245059944 hasConceptScore W4245059944C2780221984 @default.
• W4245059944 hasConceptScore W4245059944C2780559512 @default.
• W4245059944 hasConceptScore W4245059944C2780586474 @default.
• W4245059944 hasConceptScore W4245059944C3018708256 @default.
• W4245059944 hasConceptScore W4245059944C555293320 @default.
• W4245059944 hasConceptScore W4245059944C71924100 @default.
• W4245059944 hasConceptScore W4245059944C90924648 @default.
• W4245059944 hasIssue "4" @default.
• W4245059944 hasLocation W42450599441 @default.
• W4245059944 hasOpenAccess W4245059944 @default.

• next